Article thumbnail
Location of Repository

A phase I, placebo-controlled, randomized, double-blind, single ascending dose-ranging study to evaluate the safety and tolerability of a novel biophysical bronchodilator (S-1226) administered by nebulization in healthy volunteers

By Francis H. Y. Green, Richard Leigh, Morenike Fadayomi, Gurkeet Lalli, Andrea Chiu, Grishma Shrestha, Sharif G. ElShahat, David Evan Nelson, Tamer Y. El Mays, Cora A. Pieron and John H. Dennis
Publisher: Springer Nature
Year: 2016
DOI identifier: 10.1186/s13063-016-1489-8
OAI identifier:
Provided by: MUCC (Crossref)
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://trialsjournal.biomedce... (external link)
  • http://link.springer.com/conte... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.